Ironwood Pharmaceuticals | IRWD - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Acadia Pharmaceuticals USD 44.57M 32.32M 2026-06
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Akebia Therapeutics USD 9.42M 1.04M 2026-06
Almirall EUR 235.53M 22.52M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Amarin USD 18.8M 29.36M 2026-06
Ardelyx USD 28.2M 8.96M 2026-03
Astellas Pharma JPY 192.29B 7.47B 2026-06
AstraZeneca USD 22.89B 388M 2026-06
Charles River Laboratories USD 140.98M 7.03M 2026-06
Coherus Biosciences USD 13.17M 1.69M 2026-06
Emergent BioSolutions USD 112.2M 500K 2023-12
Halozyme Therapeutics USD 23.61M 9.51M 2026-06
Incyte USD 1.39B 1.16B 2026-06
Ironwood Pharmaceuticals USD 3.24M 339K 2026-03
Karyopharm Therapeutics USD 4.28M 276K 2026-03
Lexicon Pharmaceuticals USD 3M 87K 2026-03
MacroGenics USD 3.44M 845K 2026-06
Moderna USD 167M 6M 2026-06
Myriad Genetics USD 30.4M 2.2M 2026-06
Pacira USD 17.51M 3.5M 2026-06
PTC Therapeutics USD 40.45M 14.96M 2026-06
Puma Biotechnology USD 6.39M 962K 2025-09
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
Takeda JPY 446.78B 44.56B 2026-06
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12